Dilao, Elsia U.
HRN: 20-35-67 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2024
CEFTRIAXONE 1G (VIAL)
06/14/2024
06/20/2024
IV
2gm
Q24
Typhoid Fever
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes